We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

104 hedge funds and large institutions have $18M invested in Definium Therapeutics in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

388% more call options, than puts

Call options by funds: $6.76M | Put options by funds: $1.39M

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

48% more capital invested

Capital invested by funds: $12.1M → $18M (+$5.82M)

21% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 19

12% more funds holding

Funds holding: 93 → 104 (+11)

2.48% more ownership

Funds ownership: 9.76% → 12.24% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
104
Holders Change
+11
Holders Change %
+11.83%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
23
Reduced
19
Closed
9
Calls
$6.76M
Puts
$1.39M
Net Calls
+$5.37M
Net Calls Change
+$368K

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$1.81M
2
BFM
Boothbay Fund Management
New York
+$442K
3
SC
Scotia Capital
Ontario, Canada
+$367K
4
Jane Street
Jane Street
New York
+$280K
5
Goldman Sachs
Goldman Sachs
New York
+$256K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$390K
2
Citadel Advisors
Citadel Advisors
Florida
-$182K
3
BB
Busey Bank
Illinois
-$151K
4
VF
Virtu Financial
New York
-$89K
5
Group One Trading
Group One Trading
Illinois
-$72.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
$3.97K -$182K -60,603 -98%
TWC
52
TD Waterhouse Canada
Ontario, Canada
$2.92K -$331 -110 -14%
EDRH
53
Edmond de Rothschild Holding
Switzerland
$2.44K – – –
HGERS
54
Householder Group Estate & Retirement Specialist
Arizona
$2K +$903 +300 +100%
PA
55
Parallel Advisors
California
$1.75K – – –
NL
56
NVWM LLC
Pennsylvania
$1.52K +$1.25K +416 New
UBS Group
57
UBS Group
Switzerland
$1.48K -$12.4K -4,111 -91%
TIM
58
Tortoise Investment Management
New York
$1.46K – – –
EL
59
EMFO LLC
Florida
$1.1K – – –
Wells Fargo
60
Wells Fargo
California
$948 +$48 +16 +7%
NA
61
NewEdge Advisors
Louisiana
$542 – – –
AFG
62
Albion Financial Group
Utah
$484 -$575 -191 -59%
FFA
63
Farther Finance Advisors
California
$366 – – –
PGAM
64
Princeton Global Asset Management
New Jersey
$366 – – –
HI
65
Harbour Investments
Wisconsin
$366 +$271 +90 +900%
FG
66
Fairman Group
Pennsylvania
$311 +$256 +85 New
S
67
SignatureFD
Georgia
$249 – – –
AF
68
Allworth Financial
California
$242 – – –
AF
69
Arrow Financial
New York
$242 – – –
HCM
70
Hollencrest Capital Management
California
$242 – – –
US Bancorp
71
US Bancorp
Minnesota
$242 – – –
WIM
72
Westside Investment Management
California
$242 – – –
TCM
73
Tradewinds Capital Management
Washington
$194 – – –
SRCM
74
Signature Resources Capital Management
California
$194 +$160 +53 New
LI
75
Louisbourg Investments
New Brunswick, Canada
$190 +$157 +52 New
1 2
3
4 5

DFTX Hedge Fund Activity: Q4 2023 in Review

104 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q4 2023, worth a combined $18M — up 48% from $12.1M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DFTX positions and 9 closed out — a net gain of 12 holders — while 23 added to existing stakes and 19 trimmed.

The largest buyer was Ikarian Capital, opening a new position worth an estimated $1.81M. The largest seller was Millennium Management, cutting an estimated $390K.

  • 104 institutional investors held Definium Therapeutics (DFTX) as of Q4 2023, up from 93 in Q3 2023.
  • Funds reported $18M of Definium Therapeutics stock for Q4 2023, up 48% quarter-over-quarter.
  • 21 funds opened new Definium Therapeutics positions in Q4 2023 and 9 closed out, a net change of +12 holders.
  • The largest Definium Therapeutics buyer in Q4 2023 was Ikarian Capital, an estimated $1.81M added.
  • The largest Definium Therapeutics seller in Q4 2023 was Millennium Management, an estimated $390K sold.

Based on aggregated 13F filings for Q4 2023.